Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Seppo Ylä‐Herttuala, Daniel Steinberg|Journal of Clinical Investigation|1989Cited by 1.9k
Microanatomy of the Human Atherosclerotic Plaque by Single-Cell TranscriptomicsMarie A.C. Depuydt, Gerard Pasterkamp, Koen H.M. Prange et al.|Circulation Research|2020Cited by 577
Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent MechanismsJohanna Lähteenvuo, Seppo Ylä‐Herttuala, Antti Kivelä et al.|Circulation|2009Cited by 195
Growth Factor Therapy and Autologous Lymph Node Transfer in LymphedemaMarkku Lähteenvuo, Anne Saaristo, Krista Honkonen et al.|Circulation|2011Cited by 181
Silencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptorsPetri I. Mäkinen, Seppo Ylä‐Herttuala, Jari P. Lappalainen et al.|Cardiovascular Research|2010Cited by 119